Please login to the form below

Not currently logged in
Email:
Password:

BMA holds meeting over Health Bill

The British Medical Association is holding a special representative meeting today to discuss issues with the coalition government’s Health and Social Care Bill

The British Medical Association (BMA) – a professional organisation for doctors in the UK - is holding a special representative meeting (SRM) today (March 15) to discuss issues with the coalition government's Health and Social Care Bill.

The agenda of the meeting includes such topics as price competition, patient confidentiality and the pace and scale of the proposed reforms - potentially the most significant overhaul of healthcare in the UK since the formation of the NHS in 1948.

Dr Hamish Meldrum, chair of the BMA council, has been critical of the reform plans, with a recent poll of BMA members finding increasing concerns with the Bill's plans to increase competition.

Motions proposed for the SRM include that the meeting 'opposes the "Any Willing Provider" proposals in the Health Bill' the meeting 'calls on the BMA to oppose price competition between organisations providing NHS services and to lobby for an amendment to remove the provision for price competition in the legislation'; and  the meeting 'believes that the proposed reorganisation of the health service in England poses a great threat to medical training UK'.

The BMA has the full agenda for the meeting (PDF).

Watch a livestream of the meeting from the BMA, or keep track of #srmlive on Twitter.



15th March 2011

From: Healthcare

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics